SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 127 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $20,000 | -23.1% | 4,500 | 0.0% | 0.01% | -42.9% |
| Q2 2016 | $26,000 | -99.4% | 4,500 | +15971.4% | 0.01% | +600.0% |
| Q1 2016 | $4,500,000 | +10614.3% | 28 | -99.4% | 0.00% | -89.5% |
| Q4 2015 | $42,000 | +68.0% | 4,500 | 0.0% | 0.02% | 0.0% |
| Q3 2015 | $25,000 | -50.0% | 4,500 | 0.0% | 0.02% | -47.2% |
| Q2 2015 | $50,000 | -99.9% | 4,500 | 0.0% | 0.04% | -26.5% |
| Q1 2015 | $70,560,000 | +103664.7% | 4,500 | 0.0% | 0.05% | -2.0% |
| Q4 2014 | $68,000 | +38.8% | 4,500 | 0.0% | 0.05% | +28.2% |
| Q3 2014 | $49,000 | -99.9% | 4,500 | 0.0% | 0.04% | -26.4% |
| Q2 2014 | $68,715,000 | -15.5% | 4,500 | 0.0% | 0.05% | -22.1% |
| Q1 2014 | $81,360,000 | – | 4,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |